TORONTO, ONTARIO, May 07, 2012 (MARKETWIRE via COMTEX) —
      Attention: Business/Financial Editors

      The Medipattern Corporation (“Medipattern” or the “Company”) (tsx
      venture:MKI), announced today that SonoCare, LLC (“SonoCare”) has
      received Visualize:Vascular(TM) and will begin offering the 3D
      visualization procedure to patients through its 53 mobile sites
      serving communities in North and South Carolina. SonoCare brings
      cutting edge mobile imaging technology directly to the physician’s
      office and direct to patients in residential settings. Their highly
      qualified and experienced sonographers offer Ultrasound imaging
      services to patients in the convenience and comfort of familiar
      surroundings. SonoCare is dedicated to providing courteous, thorough,
      and compassionate patient care of the highest quality with
      uncompromised results and outstanding service. SonoCare is one of the
      few companies in the Carolina’s that is accredited by the
      Intersocietal Commission for the Accreditation of Echocardiography
      Laboratories (“ICAEL”). This ICAEL accreditation was achieved because
      of their commitment to quality patient care.

      “We are very pleased to be the first vascular imaging company to
      offer Visualize:Vascular in the Southeastern United States,” stated
      Mark Schubring, Clinical Director of SonoCare. “Carotid artery
      disease (“CAD”) is a major concern in our communities. SonoCare
      performs a significant number of carotid duplex exams and screenings
      each month to identify patients that may benefit from additional
      medical attention. We believe that this 3D technology for ultrasound
      will give us an edge for patients who are difficult to image.”

      “SonoCare brings state of the art ultrasound imaging technology and
      certified sonographers to the doctor’s offices that they serve. Their
      outstanding American College of Radiology (“ACR”) accredited program
      ensures exceptional patient care. Installation and training are
      expected to be completed by the end of this quarter as each site is
      phased in,” stated Jeff Collins, CEO The Medipattern Corporation. “We
      continue to grow our installed base and scanning volume is expected
      to continue to grow as we roll out our software throughout the
      Southeastern United States. We are very pleased to work with SonoCare
      and support their commitment to quality imaging procedures.”

      Upcoming Events

      Annual Meeting – MHA June 6 – 7, 2012 Brewster, MA

      SVU/SVS Annual Conference June 7 – 9, 2012 Baltimore, MD

      About the Medipattern Corporation:

      Medipattern(R) is a pioneer in the development of imaging software
      solutions that help medical practitioners to better understand
      lesions and critical anatomy. Medipattern uses its Cadenza(TM)
      technology to process images, finding the salient region of interest
      and presenting them in 2D and 3D formats that enhance the reader’s
      perception. For more information, please visit the Company’s website:

      www.medipattern.com .

      Medipattern(R) is a registered trademark of The Medipattern
      Corporation. Cadenza(TM) is a trademark of the Medipattern
      Corporation. SonoCine(R) is a registered trademark of SonoCine, Inc.

      Forward-looking statements

      This document contains forward-looking statements relating to
      Medipattern’s performance, operations, or business environment. These
      statements are based on what we believe are reasonable assumptions
      given currently available information and our understanding of
      Medipattern’s current activities. We have tried, whenever possible,
      to identify these forward-looking statements using words such as
      “anticipates,” “believes,” “estimates,” “expects,” “plans,”
      “intends,” “potential”, and similar expressions. Forward-looking
      statements are not guarantees of future performance and involve risks
      and uncertainties that are difficult to predict or control. A number
      of factors could cause actual outcomes and results to differ
      materially from those expressed in forward-looking statements. These
      factors include but are not limited to those set forth in the
      Company’s corporate filings, (posted at
      www.sedar.com ). In addition,
      these forward-looking statements relate to the date on which they are
      made. The Company disclaims any intention or obligation to update or
      revise any forward-looking statements for any reason. Readers should
      not rely on forward-looking statements.

      Neither the TSX Venture Exchange nor its Regulation Services Provider
      (as that term is defined in the policies of the TSX Venture Exchange)
      accepts responsibility for the adequacy or accuracy of this release.

              The Medipattern Corporation
              Jeff Collins
              (416) 744-0009 ext. 224
              Spinnaker Capital Markets Inc.
              Kevin O'Connor
              (416) 962-3300 ext. 226

      SOURCE: The Medipattern Corporation

      https://www.medipattern.com            mailto:ko@spinnakercmi.com

      Copyright 2012 Marketwire, Inc., All rights reserved.